Neuropeptide Y (NPY) Neuropeptide Y is a versatile molecule involved in stress response, appetite regulation, and circadian rhythm modulation
The outcome measures of interest include average drinks (Poisson distribution) and binge drinking (Binomial distribution) calculated from TLFB, AUDIT scores (Gaussian distribution), alcohol use per episode of use (Gaussian distribution) and the sedative and stimulative scores from the BAES scale (Gaussian distribution)
Gallstones and alcohol abuse stand out as the primary triggers for AP, while genetic factors, medications, and smoking also play contributing roles (Wolfe et al., 2020)
Nonetheless, to date the only FDA- and EMA-approved NRF2 activator for the treatment of relapsing-remitting MS and psoriasis is DMF, and its therapeutic potential in ALS patients in terms of efficacy, safety and tolerability, is now being evaluated in a phase-II clinical trial [313]